Personalized dosimetry of 131I-rituximab radioimmunotherapy of lymphoma

被引:0
|
作者
Boucek, J. A. [1 ]
Turner, J. [1 ]
机构
[1] Univ Western Australia, Fremantle Hosp, Fremantle, WA, Australia
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S261 / S262
页数:2
相关论文
共 50 条
  • [1] Radiation internal dosimetry in radioimmunotherapy using 131I-rituximab
    Lee, Young Sub
    Kim, Jin Su
    Kim, Kyeong Min
    Kim, Hee-Joung
    Lim, Sang Moo
    2011 IEEE NUCLEAR SCIENCE SYMPOSIUM AND MEDICAL IMAGING CONFERENCE (NSS/MIC), 2011, : 2647 - +
  • [2] Personalized Dosimetry of 131I-Rituximab Radioimmunotherapy of Non-Hodgkin Lymphoma Defined by Pharmacokinetics in Bone Marrow and Blood
    Boucek, Jan A.
    Turner, J. Harvey
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2014, 29 (01) : 18 - 25
  • [3] Safety of 131I-Rituximab Outpatient Radioimmunotherapy of Non-Hodgkin Lymphoma
    Calais, P. J.
    Turner, J. H.
    MEDICAL PHYSICS, 2011, 38 (06)
  • [4] Radioimmunotherapy with 131I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma
    Jang, Yoon Jung
    Lim, Sang Moo
    Lee, Inki
    Byun, Byung Hyun
    Lim, Ilhan
    Kim, Byung Il
    Choi, Chang Woon
    Lee, Seung-Sook
    Suh, Cheolwon
    Yoon, Dok Hyun
    Kim, Inho
    Nam, Seung-Hyun
    Lee, Mark Hong
    Won, Jong Ho
    Kong, Jee Hyun
    Jeong, Seong Hyun
    Oh, Suk Joong
    Park, Keon Woo
    Han, Jae Joon
    Song, Moo-Kon
    Yang, Sung Hyun
    Na, Im Il
    Lee, Hyo-Rak
    Shin, Dong-Yeop
    Kang, Hye Jin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (06) : 690 - 696
  • [5] Outpatient 131I-Rituximab Radioimmunotherapy for Non-Hodgkin Lymphoma A Study in Safety
    Calais, Phillipe J.
    Turner, John Harvey
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (08) : 732 - 737
  • [6] Radioimmunotherapy of newly diagnosed, advanced, low-grade lymphoma with 131I-rituximab:: The initial study
    McQuillan, A. D.
    Macdonald, W. B.
    Leahy, M. F.
    Turner, J. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 207 - 207
  • [7] Radioimmunotherapy with 131I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma
    Dong-Yeop Shin
    Byung Hyun Byun
    Kyeong Min Kim
    Joo Hyun Kang
    Ilhan Lim
    Byung Il Kim
    Seung-Sook Lee
    Chang Woon Choi
    Hye Jin Kang
    Sang Moo Lim
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 825 - 831
  • [8] Radioimmunotherapy with 131I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma
    Shin, Dong-Yeop
    Byun, Byung Hyun
    Kim, Kyeong Min
    Kang, Joo Hyun
    Lim, Ilhan
    Kim, Byung Il
    Lee, Seung-Sook
    Choi, Chang Woon
    Kang, Hye Jin
    Lim, Sang Moo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (04) : 825 - 831
  • [9] Dosimetry of I-131-rituximab radioimmunotherapy of lymphoma based upon blood/marrow pharmacokinetics
    Boucek, Jan
    Turner, J.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [10] Radioimmunotherapy with 131I-rituximab for relapsed diffuse large B cell lymphoma:: A phase II study preliminary report
    Leahy, M. F.
    McQuillan, A. D.
    Turner, J. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 219 - 219